About this Journal Submit a Manuscript Table of Contents
Prostate Cancer
Volume 2011 (2011), Article ID 386207, 11 pages
http://dx.doi.org/10.1155/2011/386207
Review Article

Beyond Diagnosis: Evolving Prostate Biopsy in the Era of Focal Therapy

Urology Department, Sunderland Royal Hospital, Kayll Road, Sunderland SR4 7TP, UK

Received 2 July 2010; Accepted 14 October 2010

Academic Editor: Alexandre R. Zlotta

Copyright © 2011 J. L. Dominguez-Escrig et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Boyle and J. Ferlay, “Cancer incidence and mortality in Europe, 2004,” Annals of Oncology, vol. 16, no. 3, pp. 481–488, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2008,” CA Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. K. Hodge, J. E. McNeal, M. K. Terris, and T. A. Stamey, “Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate,” Journal of Urology, vol. 142, no. 1, pp. 71–75, 1989. View at Scopus
  4. F. Rabbani, N. Stroumbakis, B. R. Kava, M. S. Cookson, and W. R. Fair, “Incidence and clinical significance of false-negative sextant prostate biopsies,” Journal of Urology, vol. 159, no. 4, pp. 1247–1250, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Stroumbakis, M. S. Cookson, V. E. Reuter, and W. R. Fair, “Clinical significance of repeat sextant biopsies in prostate cancer patients,” Urology, vol. 49, no. 3, pp. 113–118, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Norberg, L. Egevad, L. Holmberg, P. Sparén, B. J. Norlén, and C. Busch, “The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer,” Urology, vol. 50, no. 4, pp. 562–566, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. Applewhite, B. R. Matlaga, and D. L. McCullough, “Results of the 5 region prostate biopsy method: the repeat biopsy population,” Journal of Urology, vol. 168, no. 2, pp. 500–503, 2002. View at Scopus
  8. D. Svetec, K. McCabe, S. Peretsman et al., “Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer,” Journal of Urology, vol. 159, no. 5, pp. 1606–1608, 1998. View at Scopus
  9. M. E. Chen, P. Troncoso, D. A. Johnston, K. Tang, and R. J. Babaian, “Optimization of prostate biopsy strategy using computer based analysis,” Journal of Urology, vol. 158, no. 6, pp. 2168–2175, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Daneshgari, G. D. Taylor, G. J. Miller, and D. Crawford, “Computer simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsies,” Urology, vol. 45, no. 4, pp. 604–609, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. J. I. Epstein, P. C. Walsh, J. Sauvageot, and H. B. Carter, “Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer,” Journal of Urology, vol. 158, no. 5, pp. 1886–1890, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. H. J. Lee, K. G. Kim, S. E. Lee et al., “Role of transrectal ultrasonography in the prediction of prostate cancer: artificial neural network analysis,” Journal of Ultrasound in Medicine, vol. 25, no. 7, pp. 815–821, 2006. View at Scopus
  13. H. Y. Lee, H. J. Lee, S.-S. Byun, S. E. Lee, S. K. Hong, and S. H. Kim, “Classification of focal prostatic lesions on transrectal ultrasound (TRUS) and the accuracy of TRUS to diagnose prostate cancer,” Korean Journal of Radiology, vol. 10, no. 3, pp. 244–251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Toi, M. G. Neill, G. A. Lockwood, J. M. Sweet, L. A. Tammsalu, and N. E. Fleshner, “The continuing importance of transrectal ultrasound identification of prostatic lesions,” Journal of Urology, vol. 177, no. 2, pp. 516–520, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. H. B. Shim, S. E. Lee, H. K. Park, and J. H. Ku, “Significance of suspicious lesions at transrectal ultrasonography in men with serum prostate-specific antigen levels of <20 ng/ml,” Tumori, vol. 93, no. 2, pp. 178–181, 2007. View at Scopus
  16. R. Onur, P. J. Littrup, J. E. Pontes, and F. J. Bianco Jr., “Contemporary impact of transrectal ultrasound lesions for prostate cancer detection,” Journal of Urology, vol. 172, no. 2, pp. 512–514, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. U. M. Hamper, S. Sheth, P. C. Walsh, P. M. Holtz, and J. I. Epstein, “Stage B adenocarcinoma of the prostate: transrectal US and pathologic correlation of nonmalignant hypoechoic peripheral zone lesions,” Radiology, vol. 180, no. 1, pp. 101–104, 1991. View at Scopus
  18. F. Lee, S. T. Torp-Pedersen, D. B. Siders, P. J. Littrup, and R. D. McLeary, “Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma,” Radiology, vol. 170, no. 3, pp. 609–615, 1989. View at Scopus
  19. W. J. Ellis, M. P. Chetner, S. D. Preston, and M. K. Brawer, “Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography,” Journal of Urology, vol. 152, no. 5, pp. 1520–1525, 1994. View at Scopus
  20. B. Spajic, H. Eupic, D. Tomas, G. Stimac, B. Kruslin, and O. Kraus, “The incidence of hyperechoic prostate cancer in transrectal ultrasound-guided biopsy specimens,” Urology, vol. 70, no. 4, pp. 734–737, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. G. Fink, G. Hutarew, W. Lumper, A. Jungwirth, O. Dietze, and N. T. Schmeller, “Prostate cancer detection with two sets of ten-core compared with two sets of sextant biopsies,” Urology, vol. 58, no. 5, pp. 735–739, 2001. View at Scopus
  22. D. W. Keetch, W. J. Catalona, and D. S. Smith, “Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values,” Journal of Urology, vol. 151, no. 6, pp. 1571–1574, 1994. View at Scopus
  23. J. I. Epstein, P. C. Walsh, and H. B. Carter, “Importance of posterolateral needle biopsies in the detection of prostate cancer,” Urology, vol. 57, no. 6, pp. 1112–1116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. J. L. Gore, S. F. Shariat, B. J. Miles et al., “Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer,” Journal of Urology, vol. 165, no. 5, pp. 1554–1559, 2001. View at Scopus
  25. L. A. Eskew, R. L. Bare, and D. L. McCullough, “Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate,” Journal of Urology, vol. 157, no. 1, pp. 199–203, 1997. View at Scopus
  26. J. C. Presti Jr., G. J. O'Dowd, M. C. Miller, R. Mattu, and R. W. Veltri, “Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study,” Journal of Urology, vol. 169, no. 1, pp. 125–129, 2003. View at Scopus
  27. V. Ravery, L. Goldblatt, B. Royer, E. Blanc, M. Toublanc, and L. Boccon-Gibod, “Extensive biopsy protocol improves the detection rate of prostate cancer,” Journal of Urology, vol. 164, no. 2, pp. 393–396, 2000. View at Scopus
  28. R. J. Babaian, “Extended field prostate biopsy enhances cancer detection,” Urology, vol. 55, no. 4, pp. 453–456, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Eichler, S. Hempel, J. Wilby, L. Myers, L. M. Bachmann, and J. Kleijnen, “Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review,” Journal of Urology, vol. 175, no. 5, pp. 1605–1612, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. R. Patel and J. S. Jones, “Optimal biopsy strategies for the diagnosis and staging of prostate cancer,” Current Opinion in Urology, vol. 19, no. 3, pp. 232–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Scattoni, A. Zlotta, R. Montironi, C. Schulman, P. Rigatti, and F. Montorsi, “Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature,” European Urology, vol. 52, no. 5, pp. 1309–1322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Singh, E. I. Canto, S. F. Shariat et al., “Predictors of prostate cancer after initial negative systematic 12 core biopsy,” Journal of Urology, vol. 171, no. 5, pp. 1850–1854, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. R. A. Ashley, B. A. Inman, J. C. Routh, L. A. Mynderse, M. T. Gettman, and M. L. Blute, “Reassessing the diagnostic yield of saturation biopsy of the prostate,” European Urology, vol. 53, no. 5, pp. 976–983, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C. De Nunzio, A. Trucchi, R. Miano et al., “The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy,” Journal of Urology, vol. 181, no. 3, pp. 1069–1075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. A. V. Taira, G. S. Merrick, R. W. Galbreath et al., “Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting,” Prostate Cancer and Prostatic Diseases, vol. 13, no. 1, pp. 71–77, 2010. View at Publisher · View at Google Scholar
  36. S. F. Shariat and C. G. Roehrborn, “Using biopsy to detect prostate cancer,” Reviews in Urology, vol. 10, pp. 262–280, 2008.
  37. L. Schoenfield, J. S. Jones, C. D. Zippe et al., “The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer,” BJU International, vol. 99, no. 4, pp. 770–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. J. I. Epstein and M. Herawi, “Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care,” Journal of Urology, vol. 175, no. 3, pp. 820–834, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Scattoni, M. Roscigno, M. Freschi et al., “Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies,” Archivio Italiano di Urologia e Andrologia, vol. 77, no. 1, pp. 31–36, 2005. View at Scopus
  40. J. I. Epstein, J. Srigley, D. Grignon, and P. Humphrey, “Recommendations for the reporting of prostate carcinoma,” American Journal of Clinical Pathology, vol. 129, no. 1, pp. 24–30, 2008. View at Publisher · View at Google Scholar
  41. J. I. Epstein, D. J. Grignon, P. A. Humphrey et al., “Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia,” American Journal of Surgical Pathology, vol. 19, no. 8, pp. 873–886, 1995. View at Scopus
  42. P. G. Borboroglu, R. L. Sur, J. L. Roberts, and C. L. Amling, “Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy,” Journal of Urology, vol. 166, no. 3, pp. 866–870, 2001. View at Scopus
  43. P. G. Borboroglu, S. W. Comer, R. H. Riffenburgh, and C. L. Amling, “Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies,” Journal of Urology, vol. 163, no. 1, pp. 158–162, 2000. View at Scopus
  44. C. S. Stewart, B. C. Leibovich, A. L. Weaver, and M. M. Lieber, “Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies,” Journal of Urology, vol. 166, no. 1, pp. 86–91, 2001.
  45. N. Fleshner and L. Klotz, “Role of “saturation biopsy” in the detection of prostate cancer among difficult diagnostic cases,” Urology, vol. 60, no. 1, pp. 93–97, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. A. De La Taille, P. Antiphon, L. Salomon et al., “Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate,” Urology, vol. 61, no. 6, pp. 1181–1186, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. A. R. Patel, J. S. Jones, J. Rabets, G. DeOreo, and C. D. Zippe, “Parasagittal biopsies add minimal information in repeat saturation prostate biopsy,” Urology, vol. 63, no. 1, pp. 87–89, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. M. B. Pryor and P. F. Schellhammer, “The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies,” Clinical Prostate Cancer, vol. 1, no. 3, pp. 172–176, 2002. View at Scopus
  49. J. Simon, R. Kuefer, G. Bartsch Jr., B. G. Volkmer, R. E. Hautmann, and H.-W. Gottfried, “Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction,” BJU International, vol. 102, no. 4, pp. 459–462, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Walz, M. Graefen, F. K.-H. Chun et al., “High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series,” European Urology, vol. 50, no. 3, pp. 498–505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Descazeaud, M. Rubin, S. Chemama et al., “Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen,” World Journal of Urology, vol. 24, no. 6, pp. 676–680, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. J. C. Rabets, J. S. Jones, A. Patel, and C. D. Zippe, “Prostate cancer detection with office based saturation biopsy in a repeat biopsy population,” Journal of Urology, vol. 172, no. 1, pp. 94–97, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. J. S. Jones, A. Patel, L. Schoenfield, J. C. Rabets, C. D. Zippe, and C. Magi-Galluzzi, “Saturation technique does not improve cancer detection as an initial prostate biopsy strategy,” Journal of Urology, vol. 175, no. 2, pp. 485–488, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. B. R. Lane, C. D. Zippe, R. Abouassaly, L. Schoenfield, C. Magi-Galluzzi, and J. S. Jones, “Saturation technique does not decrease cancer detection during followup after initial prostate biopsy,” Journal of Urology, vol. 179, no. 5, pp. 1746–1750, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Scattoni, C. Maccagnano, G. Zanni et al., “Systematic extended and saturation prostate biopsy: when and how,” Minerva Urologica e Nefrologica, vol. 62, no. 2, pp. 179–192, 2010.
  56. V. Scattoni, C. MacCagnano, G. Zanni et al., “Is extended and saturation biopsy necessary?” International Journal of Urology, vol. 17, no. 5, pp. 432–447, 2010. View at Publisher · View at Google Scholar
  57. S. Peck, “Transperineal needle biopsy of the prostate,” Journal of Urology, vol. 107, no. 6, pp. 1025–1027, 1972. View at Scopus
  58. R. Clements, G. J. Griffiths, W. B. Peeling, and P. G. Ryan, “Experience with ultrasound guided transperineal prostatic needle biopsy 1985–1988,” British Journal of Urology, vol. 65, no. 4, pp. 362–367, 1990. View at Scopus
  59. B. D. Fornage, C. P. Dinney, and P. Troncoso, “Ultrasound-guided transperineal needle biopsy of the prostate after abdominoperineal resection,” Journal of Clinical Ultrasound, vol. 23, no. 4, pp. 263–265, 1995. View at Scopus
  60. E. K. Seaman, I. S. Sawczuk, M. Fatal, C. A. Olsson, and R. Shabsigh, “Transperineal prostate needle biopsy guided by transurethral ultrasound in patients without a rectum,” Urology, vol. 47, no. 3, pp. 353–355, 1996. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Y. Lee, “Technical tip: transperineal ultrasound-guided needle biopsy of the prostate in the postproctectomy patient,” Journal of Endourology, vol. 7, no. 1, pp. 75–77, 1993. View at Scopus
  62. K. A. Kirby, “Transperineal prostate needle biopsy guided by transurethral ultrasound in patients without a rectum,” Urology, vol. 49, no. 2, p. 306, 1997. View at Scopus
  63. P. S. Filderman and S. C. Jacobs, “Prostatic ultrasound in the patient without a rectum,” Urology, vol. 43, no. 5, pp. 722–724, 1994. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Shinghal and M. K. Terris, “Limitations of transperineal ultrasound-guided prostate biopsies,” Urology, vol. 54, no. 4, pp. 706–708, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. K. A. Griffiths, L. P. Ly, B. Jin, L. Chan, and D. J. Handelsman, “Transperineal ultrasound for measurement of prostate volume: validation against transrectal ultrasound,” Journal of Urology, vol. 178, no. 4, pp. 1375–1380, 2007. View at Publisher · View at Google Scholar
  66. K. Shinohara, M. Gulati, T. M. Koppie, and M. K. Terris, “Transperineal prostate biopsy after abdominoperineal resection,” Journal of Urology, vol. 169, no. 1, pp. 141–144, 2003. View at Scopus
  67. V. Ficarra, G. Novella, G. Novara et al., “The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy,” European Urology, vol. 48, no. 6, pp. 932–937, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Yamamoto, U. Kin, K. Nakamura et al., “Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5–20 ng/ml in Japan,” International Journal of Clinical Oncology, vol. 10, no. 2, pp. 117–121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. V. Ficarra, G. Martignoni, G. Novella et al., “Needle core length is a quality indicator of systematic transperineal prostate biopsy,” European Urology, vol. 50, no. 2, pp. 266–271, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Demura, T. Hioka, T. Furuno et al., “Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy,” Cancer, vol. 103, no. 9, pp. 1826–1832, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. L. G. Luciani, G. De Giorgi, C. Valotto, M. Zanin, S. Bierti, and F. Zattoni, “Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings,” Urology, vol. 67, no. 3, pp. 555–558, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Bigliocchi, M. Marini, I. Nofroni, G. Perugia, H. Shahabadi, and M. Ciccariello, “Prostate cancer detection rate of transrectal ultrasonography, digital rectal examination, and prostate-specific antigen: results of a five-year study of 6- versus 12-core transperineal prostate biopsy,” Minerva Urologica e Nefrologica, vol. 59, no. 4, pp. 395–406, 2007. View at Scopus
  73. M. Kojima, T. Hayakawa, T. Saito, H. Mitsuya, and Y. Hayase, “Transperineal 12-core systematic biopsy in the detection of prostate cancer,” International Journal of Urology, vol. 8, no. 6, pp. 301–307, 2001. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Takenaka, R. Hara, Y. Hyodo et al., “Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: a comparative study of 6 and 12 biopsy cores,” International Journal of Urology, vol. 13, no. 1, pp. 10–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. P. Emiliozzi, S. Longhi, P. Scarpone, A. Pansadoro, F. DePaula, and V. Pansadoro, “The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen,” Journal of Urology, vol. 166, no. 3, pp. 845–850, 2001. View at Scopus
  76. S. Kawakami, K. Kihara, Y. Fujii, H. Masuda, T. Kobayashi, and Y. Kageyama, “Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer,” International Journal of Urology, vol. 11, no. 8, pp. 613–618, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. T. Furuno, T. Demura, T. Kaneta et al., “Difference of cancer core distribution between first and repeat biopsy: In patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy,” Prostate, vol. 58, no. 1, pp. 76–81, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Pepe and F. Aragona, “Prostate needle biopsy: 12 vs. 18 cores—is it necessary?” Urologia Internationalis, vol. 74, no. 1, pp. 19–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. B. Rocco, O. de Cobelli, M. E. Leon et al., “Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report,” European Urology, vol. 49, no. 5, pp. 827–833, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. A. N. Vis, M. O. Boerma, S. Ciatto, R. F. Hoedemaeker, F. H. Schröder, and T. H. van der Kwast, “Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy,” Urology, vol. 56, no. 4, pp. 617–621, 2000. View at Publisher · View at Google Scholar · View at Scopus
  81. P. Emiliozzi, A. Corsetti, B. Tassi, G. Federico, M. Martini, and V. Pansadoro, “Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy,” Urology, vol. 61, no. 5, pp. 961–966, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. R. Hara, Y. Jo, T. Fujii et al., “Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy,” Urology, vol. 71, no. 2, pp. 191–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Kawakami, S. Yamamoto, N. Numao, Y. Ishikawa, K. Kihara, and I. Fukui, “Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer,” International Journal of Urology, vol. 14, no. 8, pp. 719–724, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Takenaka, R. Hara, T. Ishimura et al., “A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy,” Prostate Cancer and Prostatic Diseases, vol. 11, no. 2, pp. 134–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. K. Matsumoto, S. Egawa, T. Satoh, H. Kuruma, N. Yanagisawa, and S. Baba, “Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate gland,” International Journal of Urology, vol. 13, no. 10, pp. 1290–1295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Satoh, K. Matsumoto, T. Fujita et al., “Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy,” Urology, vol. 66, no. 1, pp. 114–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. W. Yan, H. Li, Y. Zhou et al., “Prostate carcinoma spatial distribution patterns in Chinese men investigated with systematic transperineal ultrasound guided 11-region biopsy,” Urologic Oncology, vol. 27, no. 5, pp. 520–524, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. T. C. Igel, M. K. Knight, P. R. Young et al., “Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk,” Journal of Urology, vol. 165, no. 5 I, pp. 1575–1579, 2001. View at Scopus
  89. D. M. Pinkstaff, T. C. Igel, S. P. Petrou, G. A. Broderick, M. J. Wehle, and P. R. Young, “Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience,” Urology, vol. 65, no. 4, pp. 735–739, 2005. View at Publisher · View at Google Scholar · View at Scopus
  90. S. R. J. Bott, A. Henderson, J. E. Halls, B. S. I. Montgomery, R. Laing, and S. E. M. Langley, “Extensive transperineal template biopsies of prostate: modified technique and results,” Urology, vol. 68, no. 5, pp. 1037–1041, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. B. J. Moran, M. H. Braccioforte, and D. J. Conterato, “Re-biopsy of the prostate using a stereotactic transperineal technique,” Journal of Urology, vol. 176, no. 4, pp. 1376–1381, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. B. J. Moran and M. H. Braccioforte, “Stereotactic transperineal prostate biopsy,” Urology, vol. 73, no. 2, pp. 386–388, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. G. Novara, R. Boscolo-Berto, C. Lamon et al., “Detection rate and factors predictive the presence of prostate cancer in patients undergoing ultrasonography-guided transperineal saturation biopsies of the prostate,” BJU International, vol. 105, no. 9, pp. 1242–1246, 2010. View at Publisher · View at Google Scholar
  94. H. Li, W. Yan, Y. Zhou, Z. Ji, and J. Chen, “Transperineal ultrasound-guided saturation biopsies using 11-region template of prostate: report of 303 cases,” Urology, vol. 70, no. 6, pp. 1157–1161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Tsivian, M. Kimura, L. Sun, V. Mouraviev, J. M. Mayes, and T. J. Polascik, “Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended,” BJU International, vol. 105, no. 8, pp. 1089–1092, 2010. View at Publisher · View at Google Scholar
  96. V. Mouraviev, J. M. Mayes, L. Sun, J. F. Madden, J. W. Moul, and T. J. Polascik, “Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer,” Cancer, vol. 110, no. 4, pp. 906–910, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. J. M. Mayes, V. Mouraviev, L. Sun, M. Tsivian, J. F. Madden, and T. J. Polascik, “Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?” Urologic Oncology. In press. View at Publisher · View at Google Scholar · View at Scopus
  98. R. T. Schulte, D. P. Wood, S. Daignault, R. B. Shah, and J. T. Wei, “Utility of extended pattern prostate biopsies for tumor localization: pathologic correlations after radical prostatectomy,” Cancer, vol. 113, no. 7, pp. 1559–1565, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. T. J. Polascik, J. M. Mayes, F. R. Schroeck et al., “Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy,” Cancer, vol. 115, no. 10, pp. 2104–2110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. M. K. Buyyounouski, E. M. Horwitz, A. L. Hanlon, R. G. Uzzo, G. E. Hanks, and A. Pollack, “Positive prostate biopsy laterality and implications for staging,” Urology, vol. 62, no. 2, pp. 298–303, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. C. D. Scales Jr., J. C. Presti Jr., C. J. Kane et al., “Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy—results from the SEARCH database,” Journal of Urology, vol. 178, no. 4, pp. 1249–1252, 2007. View at Publisher · View at Google Scholar
  102. M. Tsivian, D. M. Moreira, L. Sun et al., “Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weight,” Urologic Oncology. In press. View at Publisher · View at Google Scholar
  103. W. E. Barzell and M. R. Melamed, “Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate—a 4-year experience,” Urology, vol. 70, no. 6, pp. S27–S35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. A. O. Sartor, H. Hricak, T. M. Wheeler et al., “Evaluating localized prostate cancer and identifying candidates for focal therapy,” Urology, vol. 72, no. 6, pp. S12–S24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. E. D. Crawford, S. S. Wilson, K. C. Torkko et al., “Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy,” BJU International, vol. 96, no. 7, pp. 999–1004, 2005. View at Publisher · View at Google Scholar · View at Scopus
  106. G. Onik and W. Barzell, “Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy,” Urologic Oncology, vol. 26, no. 5, pp. 506–510, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. G. Onik, M. Miessau, and D. G. Bostwick, “Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management,” Journal of Clinical Oncology, vol. 27, no. 26, pp. 4321–4326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. M. Watanabe, T. Hayashi, T. Tsushima, S. Irie, T. Kaneshige, and H. Kumon, “Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection,” International Journal of Urology, vol. 12, no. 11, pp. 959–963, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Kawakami, N. Hyochi, J. Yonese et al., “Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer,” International Journal of Clinical Oncology, vol. 11, no. 2, pp. 127–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. N. Numao, S. Kawakami, M. Yokoyama et al., “Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy,” European Urology, vol. 52, no. 6, pp. 1663–1669, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Kawakami, T. Okuno, J. Yonese et al., “Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy,” European Urology, vol. 51, no. 3, pp. 675–683, 2007. View at Publisher · View at Google Scholar
  112. N. Numao, S. Kawakami, J. Yonese et al., “Three-dimensional 26-core biopsy-based patient selection criteria for nerve-sparing radical prostatectomy,” International Journal of Urology, vol. 15, no. 12, pp. 1061–1066, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. A. V. D'Amico, C. M. Tempany, R. Cormack et al., “Transperineal magnetic resonance image guided prostate biopsy,” Journal of Urology, vol. 164, no. 2, pp. 385–387, 2000. View at Scopus
  114. R. A. Cormack, A. V. D'Amico, N. Hata, S. Silverman, M. Weinstein, and C. M. Tempany, “Feasibility of transperineal prostate biopsy under interventional magnetic resonance guidance,” Urology, vol. 56, no. 4, pp. 663–664, 2000. View at Publisher · View at Google Scholar
  115. N. Hata, M. Jinzaki, D. Kacher et al., “MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility,” Radiology, vol. 220, no. 1, pp. 263–268, 2001. View at Scopus
  116. C. Tempany, S. Straus, N. Hata, and S. Haker, “MR-guided prostate interventions,” Journal of Magnetic Resonance Imaging, vol. 27, no. 2, pp. 356–367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. P. Blumenfeld, N. Hata, S. DiMaio et al., “Transperineal prostate biopsy under magnetic resonance image guidance: a needle placement accuracy study,” Journal of Magnetic Resonance Imaging, vol. 26, no. 3, pp. 688–694, 2007. View at Publisher · View at Google Scholar
  118. K. M. Pondman, J. J. Fütterer, B. ten Haken et al., “MR-guided biopsy of the prostate: an overview of techniques and a systematic review,” European Urology, vol. 54, no. 3, pp. 517–527, 2008. View at Publisher · View at Google Scholar · View at Scopus